Pharmacological Interventions: Neuromuscular Blocking Agents

Chapter

Abstract

Neuromuscular blocking agents (NMBAs) are extensively used in patients who present with acute respiratory distress syndrome (ARDS). The role of NMBAs has been extensively discussed in the past, primarily due to their potential adverse effects and the absence of clear evidence regarding their influence on prognosis. However, recent data have demonstrated that NMBAs are associated with a reduction in mortality in the most severe patients. Currently, the role of paralytics in the care of ARDS patients is proven. The positive effects of paralytics are probably due to the facilitation of protective ventilation, the prevention of ventilator-induced lung injury and the limitation of derecruitment. However, the role of NMBAs should be limited to severe and most hypoxaemic forms of moderate ARDS. NMBAs probably have a crucial role to play in the acute phase of ARDS, i.e. during the climax of lung injury, especially in association with other therapies, such as prone positioning. The use of NMBAs should always be integrated into the overall management strategy for the mechanical ventilation of ARDS patients, and NMBAs should be discontinued as soon as the patient improves sufficiently to allow for partial spontaneous breathing.

Keywords

Acute Respiratory Distress Syndrome Spontaneous Breathing Functional Residual Capacity Acute Respiratory Distress Syndrome Patient Plateau Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW, Tescher AN et al (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30:142–156CrossRefPubMedGoogle Scholar
  2. 2.
    Szakmany T, Woodhouse T (2015) Use of cisatracurium in critical care: a review of the literature. Minerva Anestesiol 81:450–460PubMedGoogle Scholar
  3. 3.
    Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefPubMedGoogle Scholar
  4. 4.
    Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336CrossRefPubMedGoogle Scholar
  5. 5.
    Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L et al (2005) Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest J 128:496–506CrossRefGoogle Scholar
  6. 6.
    Guérin C, Reignier J, Richard J-C, Beuret P, Gacouin A, Boulain T et al (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:2159–2168CrossRefPubMedGoogle Scholar
  7. 7.
    Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788–800CrossRefPubMedGoogle Scholar
  8. 8.
    Vender JS, Szokol JW, Murphy GS, Nitsun M (2004) Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit Care Med 32:S554–S561CrossRefPubMedGoogle Scholar
  9. 9.
    Needham CJ, Brindley PG (2012) The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Can J Anesth Can Anesth 59:105–108CrossRefGoogle Scholar
  10. 10.
    Stark AR, Bascom R, Frantz ID (1979) Muscle relaxation in mechanically ventilated infants. J Pediatr 94:439–443CrossRefPubMedGoogle Scholar
  11. 11.
    Bishop MJ (1984) Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiratory failure. J Am Soc Anesthesiol 60:369–371CrossRefGoogle Scholar
  12. 12.
    Coggeshall JW, Marini JJ, Newman JH (1985) Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Intern Med 145:1718–1720CrossRefPubMedGoogle Scholar
  13. 13.
    Lagneau F, D’honneur G, Plaud B, Mantz J, Gillart T, Duvaldestin P et al (2002) A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med 28:1735–1741CrossRefPubMedGoogle Scholar
  14. 14.
    Gainnier M, Roch A, Forel J-M, Thirion X, Arnal J-M, Donati S et al (2004) Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome*: Crit. Care Med 32:113–119CrossRefGoogle Scholar
  15. 15.
    Forel J-M, Roch A, Marin V, Michelet P, Demory D, Blache J-L et al (2006) Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34:2749–2757CrossRefPubMedGoogle Scholar
  16. 16.
    Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363(12):1107–1116CrossRefPubMedGoogle Scholar
  17. 17.
    Alhazzani W, Alshahrani M, Jaeschke R, Forel JM, Papazian L, Sevransky J et al (2013) Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care 17:R43CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Neto AS, Pereira VGM, Espósito DC, Damasceno MCT, Schultz MJ (2012) Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Ann Intensive Care 2:33CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Rehder K, Sessler AD, Rodarte JR (1977) Regional intrapulmonary gas distribution in awake and anesthetized-paralyzed man. J Appl Physiol 42:391–402PubMedGoogle Scholar
  20. 20.
    Tokics L, Hedenstierna G, Svensson L, Brismar B, Cederlund T, Lundquist H et al (1996) V˙/Q˙ distribution and correlation to atelectasis in anesthetized paralyzed humans. J Appl Physiol 81:1822–1833PubMedGoogle Scholar
  21. 21.
    Brismar B, Hedenstierna G, Lundquist H, Strandberg Å, Svensson L, Tokics L (1985) Pulmonary densities during Anesthesia with muscular relaxation—a proposal of atelectasis. J Am Soc Anesthesiol 62:422–428CrossRefGoogle Scholar
  22. 22.
    Hedenstierna G, Strandberg Å, Brismar B, Lundquist H, Svensson L, Tokics L (1985) Functional Residual Capacity, Thoracoabdominal Dimensions, and Central Blood Volume during General Anesthesia with Muscle Paralysis and Mechanical Ventilation. J Am Soc Anesthesiol 62:247–254CrossRefGoogle Scholar
  23. 23.
    Westbrook PR, Stubbs SE, Sessler AD, Rehder K, Hyatt RE (1973) Effects of anesthesia and muscle paralysis on respiratory mechanics in normal man. J Appl Physiol 34:81–86PubMedGoogle Scholar
  24. 24.
    Sigurdsson S, Svantesson C, Larsson A, Jonson B (2000) Elastic pressure–volume curves indicate derecruitment after a single deep expiration in anaesthetised and muscle-relaxed healthy man. Acta Anaesthesiol Scand 44:980–984CrossRefPubMedGoogle Scholar
  25. 25.
    Slutsky AS (2010) Neuromuscular blocking agents in ARDS. N Engl J Med 363:1176–1180CrossRefPubMedGoogle Scholar
  26. 26.
    Fanelli V, Morita Y, Cappello P, Ghazarian M, Sugumar B, Delsedime L et al (2016) Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine receptor-α1. J Am Soc Anesthesiol 124:132–140CrossRefGoogle Scholar
  27. 27.
    Marik PE, Kaufman D (1996) THe effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. Chest 109:1038–1042CrossRefPubMedGoogle Scholar
  28. 28.
    Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J (1999) Spontaneous breathing during ventilatory support improves ventilation–perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 159:1241–1248CrossRefPubMedGoogle Scholar
  29. 29.
    Freebairn RC, Derrick J, Gomersall CD, Young RJ, Joynt GM (1997) Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med 25:72–77CrossRefPubMedGoogle Scholar
  30. 30.
    Hraiech S, Yoshida T, Papazian L (2015) Balancing neuromuscular blockade versus preserved muscle activity: Curr. Opin Crit Care 21:26–33CrossRefGoogle Scholar
  31. 31.
    Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y (2013) The comparison of spontaneous breathing and muscle paralysis in two different severities of experimental lung injury. Crit Care Med 41:536–545CrossRefPubMedGoogle Scholar
  32. 32.
    Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care [Internet]. 2015 [cité 28 janv 2016];19. Disponible sur: http://ccforum.com/content/19/1/274
  33. 33.
    Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F et al (2005) Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 33:711–715CrossRefPubMedGoogle Scholar
  34. 34.
    Fan E, Dowdy DW, Colantuoni E, Mendez-Tellez PA, Sevransky JE, Shanholtz C et al (2014) Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med 42:849–859CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Ali NA, O’Brien JM, Hoffmann SP, Phillips G, Garland A, Finley JCW et al (2008) Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 178:261–268CrossRefPubMedGoogle Scholar
  36. 36.
    De Jonghe B, Sharshar T, Lefaucheur J et al (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867CrossRefPubMedGoogle Scholar
  37. 37.
    De Jonghe B, Bastuji-Garin S, Durand M-C, Malissin I, Rodrigues P, Cerf C et al (2007) Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 35:2007–2015CrossRefPubMedGoogle Scholar
  38. 38.
    De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L (2004) Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 30:1117–1121CrossRefPubMedGoogle Scholar
  39. 39.
    Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348–1353CrossRefPubMedGoogle Scholar
  40. 40.
    Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H et al (2007) Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175:480–489CrossRefPubMedGoogle Scholar
  41. 41.
    Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S et al (2013) Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 1:621–629CrossRefPubMedGoogle Scholar
  42. 42.
    Griffiths RD, Hall JB (2010) Intensive care unit-acquired weakness. Crit Care Med 38:779–787CrossRefPubMedGoogle Scholar
  43. 43.
    Hansen-Flaschen J, Cowen J, Raps EC (1993) Neuromuscular blockade in the intensive care unit: more than we bargained for. Am Rev Respir Dis 147:234–236CrossRefPubMedGoogle Scholar
  44. 44.
    Testelmans D, Maes K, Wouters P, Powers SK, Decramer M, Gayan-Ramirez G (2007) Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function. Intensive Care Med 33:872–879CrossRefPubMedGoogle Scholar
  45. 45.
    Hardin KA, Seyal M, Stewart T, Bonekat HW (2006) Sleep in critically ill chemically paralyzed patients requiring mechanical ventilation. Chest 129:1468–1477CrossRefPubMedGoogle Scholar
  46. 46.
    Ballard N, Robley L, Barrett D, Fraser D, Mendoza I (2006) Patients’ recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 15:86–94PubMedGoogle Scholar
  47. 47.
    Inoue S, Kawaguchi M, Sasaoka N, Hirai K, Furuya H (2006) Effects of neuromuscular block on systemic and cerebral hemodynamics and bispectral index during moderate or deep sedation in critically ill patients. Intensive Care Med 32:391–397CrossRefPubMedGoogle Scholar
  48. 48.
    Schuller PJ, Newell S, Strickland PA, Barry JJ (2015) Response of bispectral index to neuromuscular block in awake volunteers. Br J Anaesth 115:i95–103CrossRefPubMedGoogle Scholar
  49. 49.
    The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup, Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Samuel Lehingue
    • 1
    • 2
  • Sami Hraiech
    • 1
    • 2
  • Laurent Papazian
    • 1
    • 2
  1. 1.Assistance Publique – Hôpitaux de MarseilleHôpital Nord, Réanimation – Détresses Respiratoires et des Infections SévèresMarseilleFrance
  2. 2.Aix-Marseille Université, Faculté de Médecine de MarseilleMarseilleFrance

Personalised recommendations